Sale

Unavailable

Sold Out

Skip to content
Did you know that we have more than 600 products with FREE SHIPPING worldwide?
See products with FREE WORLWIDE SHIPPING

Royal Canin U/C Low Purine (2 kg)

Save €6,32
Original price €30,35
Current price €24,03

DESCRIPTION:


  • The low content of purine proteins (eg, wheat and egg flour), associated with the production of alkaline urine, helps to reduce the risk of urate stones.

  • The combination of moderate high-quality protein and low sodium levels contributes to the decrease in cystine stone formation.

  • The high levels of biotin, niacin and pantothenic acid, associated with the zinc-linoleic acid complex, help to reduce transepidermal water loss and reinforce the skin's barrier function.

  • The synergistic complex of antioxidants (vitamins E and C, taurine, lutein) prevents the degradation of cellular DNA, strengthens the immune system and neutralizes free radicals whose negative effects increase with age.


INGREDIENTS:

  • Rice, corn flour, wheat flour, dehydrated egg, animal fats, wheat gluten, minerals, corn gluten, vegetable fibres, fish oil, soy oil, fructo-oligosaccharides, borage oil, flower extract Tagette (source of lutein).


--

Royal Canin Urinary Low Purine U/C VVC 18 is indicated for: prevention of recurrence of urate, xanthine and cystine uroliths, support food for dogs with Leishmainosis and treated with xanthine oxidase inhibitors (eg allopurinol), maintenance diet for adult dogs, particularly indicated in breeds with a high risk of metabolic stone formation.

Contraindications: pregnancy, lactation, growth, treatment with urine acidifiers.

Period of administration: The duration of nutritional therapy depends on the cause of the condition.

In the case of urate stones, the food should be prescribed for a minimum period of 6 months.

In the case of irreversible problems of uric acid metabolism, the diet must be administered throughout the life of the animal.

In the case of cystine stones, Urinary U/C Low Purine can be prescribed as a first measure of treatment for 1 year.

It is essential to carry out a clinical reassessment before prolonging administration.

Sale

Unavailable

Sold Out